SCHEMBL7863249

SCHEMBL7863249

Fc1ccc(C2CCN(CC3CN(Cc4cccc(Cl)c4)CC3c3ccsc3)CC2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 11/20 0.64
DRD2 P14416 1/20 0.41
DRD4 P21917 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
RECQL P46063 1/20 0.40
CHRM2 P08172 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CHRM3 P20309 1/20 0.40
CYP2C19 P33261 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7863251 1.00 CCR5 (0.64) CCR5DRD2DRD4SIGMAR1RECQL
SCHEMBL7863366 0.91 CCR5 (0.67) CCR5SIGMAR1SLC18A3
SCHEMBL7868460 0.91 CCR5 (0.67) CCR5SIGMAR1SLC18A3
SCHEMBL7871891 0.90 CCR5 (0.56) CCR5DRD2DRD4SIGMAR1MEN1
SCHEMBL7869725 0.90 CCR5 (0.56) CCR5DRD2DRD4SIGMAR1MEN1
SCHEMBL7871208 0.88 CCR5 (0.55) CCR5SIGMAR1MEN1KMT2AATM
SCHEMBL7871214 0.88 CCR5 (0.55) CCR5SIGMAR1MEN1KMT2AATM
SCHEMBL7874880 0.86 CCR5 (0.49) CCR5
SCHEMBL7870857 0.86 CCR5 (0.56) CCR5SIGMAR1MEN1KMT2ASLC18A3
SCHEMBL7874879 0.85 CCR5 (0.55) CCR5SIGMAR1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6303593-B1 FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS MERCK & CO., INC. 2001-10-16 US claimed
US-6303593-B1 FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS MERCK & CO., INC. 2001-10-16 US disclosed